Volum 11 Numarul 1, | Srrom

Prostate cancer stages t1c

  • Prostate cancer nomogram
  • Nettles for prostatitis
  • Source: Clujul Medical.
  • Volum 11 Numarul 1, | Srrom
  • Neoplasia prostata estadiamento
  • Fenomenul de bounce PSA dupČ brahiterapia prin implant permanent cu I în cancerul de prostată localizat - factori de predicţie clinici şi dozimetrici.
  • (PPT) Curs brasov2 | Boisteanu Elena - casadeculturacluj.ro
  • Prostatita acută la o vârstă fragedă

Olinici is cell cycle and his implication in oncology. The author emphasis the importance of recent progress in the understanding of mechanisms witch governs the cell cycle and their possible implication in new strategies of cancer treatment. Ioana Brie and Valentin Cernea are the authors prostate cancer stages t1c an interesting paper about the importance of epidemio­logical requirements for the studies of radiosensitivity.

The goal of in vitro radiosensitivity research is to develop specific and rapid assays that can detect patients at for severe complications to radiotherapy.

The investigation of CER 1 involvement in ovarian cancer is the subject of a research signed by Luminiþa Leluþiu and col. Examining tissue from patients with ovarian carcinoma they suggest that it may be an associa­tion between CER1 deletions and higher grade and serous type of ovarian carcinoma.

Meniu cont utilizator

The benefit of combined treatment: neoadjuvant chemotherapy plus radiotherapy versus radiotherapy alone is evaluated by Elisabeta Ciuleanu and col. The results were similar in terms of response rate, 5 years survival or disease free survival but neoadjuvant chemotherapy could probably compensate the poor quality of radio­therapy in terms of total dose or total treatment time.

Kacsó and coworkers. For selected patients, Iodine interstitial brachytherapy offers comparable results to radical prostatectomy with accept­able urinary morbidity and less rectal toxicity and sexual dysfunction.

prostate cancer stages t1c

Quality assurance and prostate cancer stages t1c control in radiotherapy are important parameters for any modern radiotherapy centre. Nicolae Todor and Rareş Buiga using a simulation program in Visual Basic for Tratamentul tulpinii prostatitei investigate the graph of soțul medicament prostatita data for a binary variable.

The imunohystochimic evaluation of galectin-3 on a set of ovarian tumors is the practical example. Prostate cancer stages t1c and coworkers The paper report a breast tumor showing two different histological appearances: a signet ring cell carcinoma with invasive and with in situ patterns and a classical ductal invasive and in situ carcinoma. The signet-ring cell carcinoma of the breast is a very rare tumor.

Navigare principală

Viorica Nagy exposes the recommendations of these two professional societies. We wish you to enjoy the reading prostate cancer stages t1c this issue of our journal. Dana Cernea 5 Cell Cycle. Implications in Oncology.

prostate cancer stages t1c

Part I D. An initial step in malignant transformation is represented by the unregulation of cell division. Recent advances in the understanding of the mechanisms which govern the cell cycle are likely to provide information pertinent to the prediction of clinical behavior and might open new avenues for the treatment of cancer.

Cancer de prostata: simptome, tratament, prevenire | casadeculturacluj.ro

This requires appropriate epidemiological study designs, because the failure to prove the usefullness of such an assay may be due not solely to the assay itself but also to the choice of study methodology.

The present paper presents the epidemiologic requirements specific for the good studies on RS and recommendations for future research. Part II. Luminiţa Leluţiu1, S. Imreh2, C. Olinici1,3, N. Examining tissue from 13 ovarian carcinoma cases with CER1 and centromere specific probes, we detected CER1 deletions in 10 cases.

We suggest that it may be association between CER1 deletions and higher grade, serous type of ovarian carcinoma. Ciuleanu1,2, N. Todor1, N. Results: pts.

prostate cancer stages t1c

Key words: Nasopharingeal carcinoma, Neoadjuvant chemotherapy. Hannoun-Levi2, S. Marcié 2, P. Y Marcy2Quintens3J.

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer?

Amiel3, J. Median age was 64 years range 54— Median pre-treatment PSA was 7. The median prostate volume was 37 cc range 60 and the prescribed dose for 6 men pre-TG43 respectively Gy TG for all others. The median follow-up was 14 months 6- 36 months. There were no acute or late rectal toxicity RTY higher than G2, as only At 3 vs. All patients were discharged 24 hours after the implant.

prostate cancer stages t1c

Conclusions: for selected patients, I TPI BT offers efficacy comparable to radical prostatectomy or conformal radiotherapy, with acceptable urinary morbidity, less severe rectal toxicity and sexual dysfunction, at least for the first 2 years after the implant. Cernea¹ ², A. Chiş¹, D. Dordai¹, V. Bogdan¹, Ruxandra Fizeşan¹, N. This implies that both the parameters related to the patient diagnosis, decision, indication for treatment, follow-up and also the procedures related to the technical aspects, achievement of safe effective treatment were subjected to careful quality control.

Fenomenul de bounce PSA dupć brahiterapia - Revista Urologia

Audit of individual radiotherapy prscriptions will identify apparent planning or prescription errors that could be corrected prior to the initiation of therapy. The objectives for audit for radiotherapy treatment policy will review patients management: indication, the choice of target volume, the prescribed dose, the adequacy of target volume coverage and protection of normal structure.

The paper shows a practical method to evaluate the correctness of data.

prostate cancer stages t1c

Olinici1,2, Doiniţa Crişan1, Ioana L. Muntean2, Liliana Resiga2 1U. Although their histogenesis is controversial, most cases are regarded as variants of infiltrating lobular carcinomas.

  1. Cancerul Prostatei | Centru Oncologie Severin
  2. Cancer de prostata - Tot ce trebuie sa stii | Cancer
  3. Se consideră că beneficiul terapie de privare androgenica TDA incipiente este incert și trebuie echilibrat cu riscul efectelor secundare ale TDA.

This paper reports a breast tumor showing two different histologic appearances: a signet ring cell carcinoma with invasive and with in situ patterns and a classical ductal invasive and in situ carcinoma. The histological features, the immunoreactivity for estrogen and progesterone receptors and the lack of lobular changes suggest that the signet-ring cell component arose from the ductal epithelium.